Supriya Lifescience [SUPRIYA] vs Biocon [BIOCON] Detailed Stock Comparison

Supriya Lifescience

NSE

Biocon

NSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Supriya Lifescience wins in 12 metrics, Biocon wins in 8 metrics, with 0 ties. Supriya Lifescience appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Supriya Lifescience	Biocon	Better
P/E Ratio (TTM)	27.94	110.22	Supriya Lifescience
Price-to-Book Ratio	5.24	1.96	Biocon
Debt-to-Equity Ratio	0.54	66.26	Supriya Lifescience
PEG Ratio	0.48	35.78	Supriya Lifescience
EV/EBITDA	19.92	19.34	Biocon
Profit Margin (TTM)	26.99%	2.44%	Supriya Lifescience
Operating Margin (TTM)	33.41%	7.46%	Supriya Lifescience
EBITDA Margin (TTM)	33.41%	7.46%	Supriya Lifescience
Return on Equity	20.74%	3.66%	Supriya Lifescience
Return on Assets (TTM)	14.77%	1.72%	Supriya Lifescience
Free Cash Flow (TTM)	$22.99M	$17.18B	Biocon
Dividend Yield	0.12%	0.26%	Biocon
1-Year Return	29.91%	4.09%	Supriya Lifescience
Price-to-Sales Ratio (TTM)	7.54	3.00	Biocon
Enterprise Value	$51.95B	$623.85B	Biocon
EV/Revenue Ratio	7.46	3.96	Biocon
Gross Profit Margin (TTM)	70.22%	64.06%	Supriya Lifescience
Revenue per Share (TTM)	$87	$131	Biocon
Earnings per Share (Diluted)	$23.35	$3.22	Supriya Lifescience
Beta (Stock Volatility)	0.19	0.23	Supriya Lifescience

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Supriya Lifescience vs Biocon Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Supriya Lifescience	0.78%	-1.11%	-8.94%	-1.73%	-9.19%	-13.95%
Biocon	1.51%	-4.69%	-6.38%	8.15%	-0.29%	-3.77%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Supriya Lifescience	29.91%	80.42%	36.94%	36.94%	36.94%	36.94%
Biocon	4.09%	15.17%	-9.94%	358.88%	505.53%	835.92%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Supriya Lifescience (SUPRIYA): View Full Stock Overview

Biocon (BIOCON): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Supriya Lifescience vs Biocon

Metric	SUPRIYA	BIOCON
Market Information
Market Cap i	₹52.51B	₹473.64B
Market Cap Category	Mid cap	Large cap
10 Day Avg. Volume i	160,067	4,799,933
90 Day Avg. Volume i	233,295	4,918,489
Last Close	₹656.00	₹360.25
52 Week Range	₹495.65 - ₹842.00	₹291.00 - ₹406.00
% from 52W High	-22.09%	-11.27%
All-Time High	₹842.00 (Mar 31, 2025)	₹487.75 (Dec 21, 2020)
% from All-Time High	-22.09%	-26.14%
Growth Metrics
Quarterly Revenue Growth	0.16%	0.15%
Quarterly Earnings Growth	0.36%	-0.95%
Financial Health
Profit Margin (TTM) i	0.27%	0.02%
Operating Margin (TTM) i	0.33%	0.07%
Return on Equity (TTM) i	0.21%	0.04%
Debt to Equity (MRQ) i	0.54	66.26
Cash & Liquidity
Book Value per Share (MRQ)	₹124.44	₹180.66
Cash per Share (MRQ)	₹9.88	₹38.10
Operating Cash Flow (TTM) i	₹1.65B	₹17.78B
Levered Free Cash Flow (TTM) i	₹-203,502,496	₹10.13B
Dividends
Last 12-Month Dividend Yield i	0.12%	0.26%
Last 12-Month Dividend i	₹0.80	₹1.00

Valuation & Enterprise Metrics Analysis: Supriya Lifescience vs Biocon

Metric	SUPRIYA	BIOCON
Price Ratios
P/E Ratio (TTM) i	27.94	110.22
Forward P/E i	22.01	35.78
PEG Ratio i	0.48	35.78
Price to Sales (TTM) i	7.54	3.00
Price to Book (MRQ) i	5.24	1.96
Market Capitalization
Market Capitalization i	₹52.51B	₹473.64B
Enterprise Value i	₹51.95B	₹623.85B
Enterprise Value Metrics
Enterprise to Revenue i	7.46	3.96
Enterprise to EBITDA i	19.92	19.34
Risk & Other Metrics
Beta i	0.19	0.23
Book Value per Share (MRQ) i	₹124.44	₹180.66

Financial Statements Comparison: Supriya Lifescience vs Biocon

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	SUPRIYA	BIOCON
Revenue/Sales i	₹1.84B	₹39.10B
Cost of Goods Sold i	₹548.26M	₹14.05B
Gross Profit i	₹1.29B	₹25.05B
Research & Development i	N/A	₹-346.00M
Operating Income (EBIT) i	₹615.04M	₹2.94B
EBITDA i	₹705.39M	₹8.29B
Pre-Tax Income i	₹640.60M	₹969.00M
Income Tax i	₹136.80M	₹77.00M
Net Income (Profit) i	₹503.82M	₹892.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	SUPRIYA	BIOCON
Cash & Equivalents i	₹760.57M	₹32.27B
Total Current Assets i	₹4.37B	₹162.86B
Total Current Liabilities i	₹821.62M	₹143.34B
Long-Term Debt i	₹50.57M	₹129.45B
Total Shareholders Equity i	₹9.97B	₹277.13B
Retained Earnings i	N/A	₹189.59B
Property, Plant & Equipment i	₹4.51B	₹4.32B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	SUPRIYA	BIOCON
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	SUPRIYA	BIOCON
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	160,067	4,799,933
Average Daily Volume (90 Day) i	233,295	4,918,489
Shares Outstanding i	80.48M	1.20B
Float Shares i	25.39M	523.49M
% Held by Insiders i	0.72%	0.56%
% Held by Institutions i	0.05%	0.24%

Dividend Analysis & Yield Comparison: Supriya Lifescience vs Biocon

Metric	SUPRIYA	BIOCON
Last 12-Month Dividend i	₹0.80	₹1.00
Last 12-Month Dividend Yield i	0.12%	0.26%
3-Year Avg Annual Dividend i	₹0.67	₹1.33
3-Year Avg Dividend Yield i	0.18%	0.36%
3-Year Total Dividends i	₹2.00	₹4.00
Ex-Dividend Date	Sep 20, 2024	Jul 04, 2025

Supriya Lifescience [SUPRIYA] vs Biocon [BIOCON] Detailed Stock Comparison